Lonza | LONN - Ebit

Stock Price
528.50
Daily Change
-7.90 -1.47%
Monthly
-4.26%
Yearly
-9.47%
Q1 Forecast
523.37

Lonza reported CHF673M in EBIT for its fiscal semester ending in June of 2025.





Ebit Change Date
Akzo Nobel EUR 217M 80M Dec/2025
Alcon AG USD 334M 84M Sep/2025
Almirall EUR 43.02M 28.78M Jun/2025
AstraZeneca USD 2.97B 4.48B Dec/2025
BASF EUR 493M 334M Sep/2025
Bayer EUR -399M 363M Sep/2025
Beiersdorf EUR 816M 370M Jun/2025
Covestro EUR 5.39B 5.34B Sep/2025
Demant DKK 2.07B 201M Dec/2025
Fresenius EUR 574M 14M Sep/2025
Fresenius Medical Care EUR 449.94M 18.94M Sep/2025
Geberit CHF 195.5M 42.2M Jun/2025
Genmab DKK 432M 900.27M Jun/2025
Givaudan CHF 756M 221M Jun/2024
GlaxoSmithKline GBP 1.44B 1.35B Dec/2025
GN Store Nord DKK 570M 230M Dec/2025
Hikma Pharmaceutical USD 317M 85M Dec/2024
Johnson Matthey GBP 142M 89M Dec/2025
Merck EUR 1.21B 180M Sep/2025
Novartis USD -9.19B 13.87B Jun/2025
Philips EUR 719M 390M Dec/2025
Roche Holding CHF 9.56B 2.1B Dec/2025
Sanofi EUR 1.7B 2.17B Dec/2025
Sika AG CHF 798.1M 93.6M Jun/2025
Smith & Nephew USD 440M 50M Dec/2025
Solvay EUR 44M 106M Jun/2025
UCB EUR 502M 168M Dec/2024